Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Bill Steinman
Contributing Editor

Job: Director, Ethics & Compliance Franchise Advisor: Ophtha/Respiratory

Job Title: Director, Ethics & Compliance Franchise Advisor: Ophtha/Respiratory

Employer: Novartis

Location: East Hanover, New Jersey USA

Description: To provide independent, strategic business partnership with Franchise Leadership of two Franchises (Ophthalmics/Respiratory) to anticipate and identify proactive strategies/solutions to address business needs and potential risks, and help ensure that activities and processes comply with all applicable NPC policies, laws, regulations and professional codes of conduct.… Continue Reading

Job: Director, Ethics & Compliance Functional Advisor, Patient Access/Health Policy

Job Title: Director, Ethics & Compliance Functional Advisor, Patient Access/Health Policy

Employer: Novartis

Location: East Hanover, New Jersey USA

Description: To provide independent, strategic business partnership with the Patient Access/Health Policy (PA/HP) Function to anticipate and identify proactive strategies/solutions to address business needs and potential risks, and help ensure that activities and processes comply with all applicable NPC policies, laws, regulations and professional codes of conduct.… Continue Reading

Compliance Alert: Gift-giving, rebates and kickbacks in South Korea

It is customary to send gifts and make cash donations in the regular course of business in South Korea. Exchanging gifts is a deeply rooted custom in Korean society, and this practice has historically been the source of various compliance issues for multinational companies operating in South Korea.… Continue Reading

Novartis pays $25 million to SEC to resolve China FCPA offenses

Pharma giant Novartis AG agreed Wednesday to pay $25 million to settle charges that it violated the Foreign Corrupt Practices Act when two China-based subsidiaries bribed doctors and others to prescribe its drugs. 

Novartis subsidiaries gave money and gifts to doctors and other health care professionals in China.… Continue Reading